Development of Alzheimer's Disease Biomarkers: From CSF- to Blood-Based Biomarkers.

Biomedicines · 2022 · PMC9025524 · PMID 35453600

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

may be significantno p-value reported

The roles of these genetic variants in AD pathogenesis and progression are largely unknown; however, the function of the genotypes in clinical classification using ATN framework may be significant.

also in 13,097 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.